Additional file 4: of Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma

Cheng‐Lung Hsu, Hsin-Pai Li, Lang‐Ming Chi et al.|Figshare|2018

Cited by 0